Imatinib Completed Phase 2 / 3 Trials for Chronic Lung Diseases / Idiopathic Pulmonary Fibrosis (IPF) / Pulmonary Fibrosis Educational/Counseling/Training

IndicationsStatusPurposePhase
CompletedEducational/Counseling/Training2 / 3
clinicaltrials.gov IdentifierTitleDrugs